Abstract:
The present invention provides 4-(3-Amino-phenyl)-5,6-dihydro-4H-[1,3]oxazin-2-ylamines of formula (I) having BACE1 and/or BACE2 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and/or prophylactic treatment of e.g. Alzheimer's disease and type 2 diabetes.
Abstract:
The present invention relates to 2-Amino-5,5-difluoro-5,6-dihydro-4H-[1,3]oxazin-4-yl)- phenyl]-amide derivatives of formula (I) having BACE1 and/or BACE2 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and/or prophylactic treatment of e.g. Alzheimer's disease and type 2 diabetes.
Abstract:
It comprises a process for the production of delmopinol or a pharmaceutically acceptable salt and/or a solvate thereof, by subjecting the compound of formula (II) where R1 and R2 are the same or different, independently selected from the group consisting of H, (C1-C6) alkyl or, alternatively, R1 and R2 form, together with the carbon atom to which they are attached, a (C5-C6) cycloalkyl radical; and R3 is a radical selected from the group consisting of CF3, (C1-C4) alkyl, phenyl, and phenyl mono- ordisubstituted by a radical selected from the group consisting of (C1-C4)-alkyl, halogen and nitro to a deprotection and cyclisation reaction. The process is useful to prepare delmopinol or its salts on an industrial scale. The compound of formula (II) is new and also forms part of the present invention, as well as its preparation process and other new intermediates of said preparation process. .
Abstract:
Novel naphthalene derivatives represented by general formula (1), which exhibit an excellent fibrinolysis accelerating effect and are useful as orally administrable antithrombotic or thrombolytic agents.
Abstract:
The present invention relates to functionalized ploy(2-oxazoline) polymers, which are very suitable as a carrier and/or delivery vehicle (conjugate) of drugs, such as small therapeutic molecules and bio-pharmaceuticals. These polymers are characterized in that they comprise repeating units that are represented by the following formula -[N(R 1 )-(CHR 2 )m]- wherein R 1 is R 3 -(CHR 4 )n-CONH-R 5 ; R 2 is selectd from H and optionally substituted C 1-5 alkyl; R 3 is CH 2 CO, C(O)O, C(O)NH OR C(S)NH; R 4 is selected from H and optionally substituted C 1-5 alkyl; R 5 is H; an C 1-5 alkyl; aryl; or a moiety comprising a functional group that can be used for conjugation; m is 2 or 3 and n is 1-5; or n is 0 and R 3 is CH 2 . The invention relates further to a conjugate of these polyoxazoline polymers with at least one active moiety, such as a therapeutic moiety, a targeting moiety and/or diagnostic moiety, and to the use of these conjugates in the therapeutic treatment or prophylactic treatment or diagnosis of a disease or disorder.
Abstract:
The present invention provides compounds of formula I having BACE1 and/or BACE2 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and/or prophylactic treatment of e.g. Alzheimer's disease and type 2 diabetes.
Abstract:
This invention relates to 5,6-dihydro-4H-[1,3]oxazin-2-ylamine compounds of the formula (I) wherein R 1 to R 5 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are BACE2 inhibitors and can be used as medicaments for the treatment or prevention of diseases such as diabetes.
Abstract:
The invention relates to novel compounds of formula (I), wherein A means -CH2O- or -CH=N-; R1 is C1-C4-alkyl or cyclopropyl; R2 means C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkinyl or C1-C6-alkyl which is substituted with 1 to 5 fluor atoms; R3 means the radicals as defined in the description; R5 is hydrogen, C1-C4-alkyl, C1-C2-alkoxymethyl, C1-C2-alkylthiomethyl, C1-C3-halogenalkylmethyl, C2-C4-alkenyl, C2-C4-alkinyl, C1-C3-alkylcarbonyl or C1-C2-alkoxycarbonyl and R6 means C1-C4-alkyl. Said compounds are useful in agriculture for combatting acarina and insects and for preventing cultivated plants from being infected with phytopathogen fungi.
Abstract:
Compounds of formula (I), and their N-oxides and agriculturally-suitable salts, are disclosed which are useful as arthropodicides wherein: A is selected from the group direct bond, C1-C3 alkylene and C2-C4 alkenylene; Q is selected from the group phenyl, pyridyl, thienyl, furyl and naphthyl, each ring substituted with R , R and R ; each E is independently selected from the group C1-C4 alkyl and C1-C4 haloalkyl; Z is selected from the group O and S; R and R are independently selected from the group H, 1-2 halogen, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, CN and NO2; q is 0, 1, 2 or 3; and R , R and R are as defined in the disclosure. Also disclosed are compositions containing the compounds of formula (I) and a method for controlling arthropods which involves contacting the arthropods or their environment with an effective amount of a compound of formula (I).